PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Fostair NEXThaler (beclometasone and formoterol) - Asthma
PAD Profile : Fostair NEXThaler (beclometasone and formoterol) - Asthma
Keywords :
ICS LABAs, ICS/LABAs, inhaled corticosteroids, long-acting beta agonists, respiratory, asthmatics, MART action plans, maintenance and reliever therapy
Brand Names Include :
Fostair NEXThaler
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Montelukast
- Theophylline
- Easyhaler (Salbutamol)
- Clenil Modulite (beclometasone)
- Easyhaler (Beclometasone)
- Easyhaler (Budesonide)
- Fostair (Beclometasone and formoterol)
- Budelin Novolizer (budesonide)
- Dupilumab
- Airflusal (Salmeterol/Fluticasone) MDI
- Aerivio Spiromax (Fluticasone/Salmeterol) DPI
- Ventolin Accuhaler (salbutamol)
- Sereflo Ciphaler (Salmeterol / Fluticasone) DPI
- Campona Airmaster (Salmeterol / Fluticasone) DPI
- Salbutamol
- Terbutaline sulphate
- Budesonide
- Salamol Easi-Breathe
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
06 March 2019
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Fostair® (beclometasone / formoterol) metered dose inhaler is the locally preferred ICS/LABA.
Fostair Nexthaler ® breath-actuated inhaler is the preferred dry powder ICS/LABA device.
It is licensed for Maintenance and Reliever Therapy (MART) and is available in a full range of doses. See MART action plan document below.
Fostair devices are not licensed in under 18's.
Prescribe inhaler devices by BRAND to ensure consistency and avoid confusion.
See Asthma Guidelines below.
Associated BNF Codes
03. Respiratory System
03.02.00. Corticosteroids (respiratory)